At the end of last month, Misonix and Sonora Medical Systems received FDA approval for a 3-D surface-rendering tool called BabyFace that, when plugged into a standard ultrasound system, transforms a 2-D image of a fetus into 3-D.The system uses a
At the end of last month, Misonix and Sonora Medical Systems received FDA approval for a 3-D surface-rendering tool called BabyFace that, when plugged into a standard ultrasound system, transforms a 2-D image of a fetus into 3-D.
The system uses a transducer with an integrated motion-tracking sensor and a compact electronic box with a miniature computer. Product developers of BabyFace say the software can connect easily to conventional ultrasound systems.
Sonora, a distributor of previously owned and refurbished medical imaging systems, developed BabyFace with Biomedicom of Israel. Biomedicom is a spin-off of Mountain View, CA-based Silicon Graphics. Misonix President Michael A. McManus said his company will market the rendering tool aggressively. Misonix has a larger than 50% interest in Sonora.
Integrated Equipment Solutions, distributor of BabyFace, showed off the software at the American Institute of Ultrasound Medicines convention in San Francisco this month. BabyFace will also be shown at the May 2224 American College of Obstetricians and Gynecologists meeting in San Francisco.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.